Literature DB >> 25893882

Inherited neurovascular diseases affecting cerebral blood vessels and smooth muscle.

Christine Sam1, Fei-Feng Li, Shu-Lin Liu.   

Abstract

Neurovascular diseases are among the leading causes of mortality and permanent disability due to stroke, aneurysm, and other cardiovascular complications. Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and Marfan syndrome are two neurovascular disorders that affect smooth muscle cells through accumulation of granule and osmiophilic materials and defective elastic fiber formations respectively. Moyamoya disease, hereditary hemorrhagic telangiectasia (HHT), microcephalic osteodysplastic primordial dwarfism type II (MOPD II), and Fabry's disease are disorders that affect the endothelium cells of blood vessels through occlusion or abnormal development. While much research has been done on mapping out mutations in these diseases, the exact mechanisms are still largely unknown. This paper briefly introduces the pathogenesis, genetics, clinical symptoms, and current methods of treatment of the diseases in the hope that it can help us better understand the mechanism of these diseases and work on ways to develop better diagnosis and treatment.

Entities:  

Mesh:

Year:  2015        PMID: 25893882     DOI: 10.1007/s11011-015-9668-y

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  78 in total

Review 1.  Moyamoya disease.

Authors:  M Fukui; S Kono; K Sueishi; K Ikezaki
Journal:  Neuropathology       Date:  2000-09       Impact factor: 1.906

Review 2.  Moyamoya disease: a review of the disease and anesthetic management.

Authors:  Tariq Parray; Timothy W Martin; Saif Siddiqui
Journal:  J Neurosurg Anesthesiol       Date:  2011-04       Impact factor: 3.956

3.  Notch3 ectodomain is a major component of granular osmiophilic material (GOM) in CADASIL.

Authors:  Akira Ishiko; Atsushi Shimizu; Eiichiro Nagata; Keikichi Takahashi; Takeshi Tabira; Norihiro Suzuki
Journal:  Acta Neuropathol       Date:  2006-07-27       Impact factor: 17.088

4.  CNS manifestations of Fabry's disease.

Authors:  Andreas Fellgiebel; Matthias J Müller; Lionel Ginsberg
Journal:  Lancet Neurol       Date:  2006-09       Impact factor: 44.182

5.  National mutation study among Danish patients with hereditary haemorrhagic telangiectasia.

Authors:  P M Tørring; K Brusgaard; L B Ousager; P E Andersen; A D Kjeldsen
Journal:  Clin Genet       Date:  2013-10-03       Impact factor: 4.438

6.  A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7.

Authors:  Pinar Bayrak-Toydemir; Jamie McDonald; Nurten Akarsu; Reha M Toydemir; Fernanda Calderon; Timur Tuncali; Wei Tang; Franklin Miller; Rong Mao
Journal:  Am J Med Genet A       Date:  2006-10-15       Impact factor: 2.802

Review 7.  Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification.

Authors:  Toshio Fukutake
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-01-07       Impact factor: 2.136

Review 8.  The role of genetics in stroke.

Authors:  John Francis; Senthil Raghunathan; Pradeep Khanna
Journal:  Postgrad Med J       Date:  2007-09       Impact factor: 2.401

9.  A novel susceptibility locus for moyamoya disease on chromosome 8q23.

Authors:  Kaoru Sakurai; Yasue Horiuchi; Hidetoshi Ikeda; Kiyonobu Ikezaki; Takashi Yoshimoto; Masashi Fukui; Tadao Arinami
Journal:  J Hum Genet       Date:  2004       Impact factor: 3.172

10.  Novel FBN1 gene mutation and maternal germinal mosaicism as the cause of neonatal form of Marfan syndrome.

Authors:  Antonín Sípek; Lucie Grodecká; Alice Baxová; Petra Cibulková; Magdaléna Dvořáková; Stella Mazurová; Martin Magner; Jiří Zeman; Tomáš Honzík; Tomáš Freiberger
Journal:  Am J Med Genet A       Date:  2014-03-25       Impact factor: 2.802

View more
  7 in total

1.  When and why is surgical revascularization indicated for the treatment of moyamoya syndrome in patients with RASopathies? A systematic review of the literature and a single institute experience.

Authors:  Marcello Scala; Pietro Fiaschi; Valeria Capra; Maria Luisa Garrè; Domenico Tortora; Marcello Ravegnani; Marco Pavanello
Journal:  Childs Nerv Syst       Date:  2018-05-24       Impact factor: 1.475

2.  Tolosa-Hunt syndrome and comorbidity of obsessive compulsive disorder and aortic aneurysm.

Authors:  Mehmet Emin Ceylan; Alper Evrensel; Cemal Onur Noyan; Aslıhan Dönmez
Journal:  BMJ Case Rep       Date:  2016-11-21

3.  Identification of two novel critical mutations in PCNT gene resulting in microcephalic osteodysplastic primordial dwarfism type II associated with multiple intracranial aneurysms.

Authors:  Fei-Feng Li; Xu-Dong Wang; Min-Wei Zhu; Zhi-Hong Lou; Qiong Zhang; Chun-Yu Zhu; Hong-Lin Feng; Zhi-Guo Lin; Shu-Lin Liu
Journal:  Metab Brain Dis       Date:  2015-08-01       Impact factor: 3.584

4.  Combined effects of age and polymorphisms in Notch3 in the pathogenesis of cerebral infarction disease.

Authors:  Chun-Yu Zhu; Yue Wang; Qing-Xuan Zeng; Yu Qian; Huan Li; Zi-Xia Yang; Ya-Mei Yang; Qiong Zhang; Fei-Feng Li; Shu-Lin Liu
Journal:  Metab Brain Dis       Date:  2016-07-02       Impact factor: 3.584

5.  Ocular characteristics in a variant microcephalic primordial dwarfism type II.

Authors:  Wan-Ju Chen; Fu-Chin Huang; Min-Hsiu Shih
Journal:  BMC Pediatr       Date:  2019-09-11       Impact factor: 2.125

Review 6.  Blood-brain barrier-on-a-chip: Microphysiological systems that capture the complexity of the blood-central nervous system interface.

Authors:  Duc Tt Phan; R Hugh F Bender; Jillian W Andrejecsk; Agua Sobrino; Stephanie J Hachey; Steven C George; Christopher Cw Hughes
Journal:  Exp Biol Med (Maywood)       Date:  2017-02-14

7.  RNF213 variant in a patient with Legius syndrome associated with moyamoya syndrome.

Authors:  Giulia Romanisio; Cristina Chelleri; Marcello Scala; Gianluca Piccolo; Barbara Carlini; Laura Gatti; Valeria Capra; Federico Zara; Anna Bersano; Marco Pavanello; Patrizia De Marco; Maria Cristina Diana
Journal:  Mol Genet Genomic Med       Date:  2021-05-03       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.